Physiomics PLC (PYC)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.41p
Buy
0.44p
0.005p (+1.18%)
Physiomics PLC is engaged in providing outsourced systems and computational biology services to pharmaceutical companies.
Prices updated at 15 May 2025, 15:16 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. James Simon Millen
CEO
Dr. Peter Joseph Sargent
Most recent earnings
30 Jun 2024
Fiscal year end
30 Jun 2024
Employees
7
Head office
140 Eastern Avenue
Oxfordshire
United Kingdom
OX14 4SB
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Dr. James Simon Millen Non-Executive Director, Chairman | - | - | - | - | - |
Dr. Peter Joseph Sargent Executive Director, Chief Executive Officer | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| No data | ||||||
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 07 Nov 2024 | Purchase | Dr. Peter Joseph Sargent | 0.66 | 3,030 | 459,090 | 0.34 | - |
Please note that past performance is not a reliable indicator of future returns.
